Free Trial
NASDAQ:ANGO

AngioDynamics (ANGO) Stock Price, News & Analysis

$7.18
+0.23 (+3.31%)
(As of 04:31 PM ET)
Today's Range
$6.86
$7.19
50-Day Range
$5.51
$7.51
52-Week Range
$5.26
$9.43
Volume
562,979 shs
Average Volume
547,463 shs
Market Capitalization
$287.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.25

AngioDynamics MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
70.6% Upside
$12.25 Price Target
Short Interest
Healthy
4.44% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.99
Upright™ Environmental Score
News Sentiment
0.34mentions of AngioDynamics in the last 14 days
Based on 20 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.40) to ($0.29) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.19 out of 5 stars

Medical Sector

153rd out of 896 stocks

Surgical & Medical Instruments Industry

20th out of 96 stocks

ANGO stock logo

About AngioDynamics Stock (NASDAQ:ANGO)

AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

ANGO Stock Price History

ANGO Stock News Headlines

When Will AngioDynamics, Inc. (NASDAQ:ANGO) Breakeven?
Breaking News: Elon Musk Invents New Type of A.I. (Shocking)
Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.
AngioDynamics' (ANGO) "Buy" Rating Reaffirmed at HC Wainwright
AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Update
374 Student Wins Last Week: Are You Next?
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
AngioDynamics (NASDAQ:ANGO) Updates FY25 Earnings Guidance
AngioDynamics (NASDAQ:ANGO) Issues FY 2025 Earnings Guidance
See More Headlines
Receive ANGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AngioDynamics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/16/2024
Today
7/19/2024
Next Earnings (Estimated)
10/02/2024
Fiscal Year End
5/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:ANGO
CUSIP
03475V10
Employees
760
Year Founded
1988

Price Target and Rating

Average Stock Price Target
$12.25
High Stock Price Target
$14.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+78.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-52,440,000.00
Pretax Margin
-63.06%

Debt

Sales & Book Value

Annual Sales
$303.91 million
Cash Flow
$3.97 per share
Book Value
$5.13 per share

Miscellaneous

Free Float
38,012,000
Market Cap
$275.21 million
Optionable
Optionable
Beta
0.66

Social Links

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives


ANGO Stock Analysis - Frequently Asked Questions

How have ANGO shares performed this year?

AngioDynamics' stock was trading at $7.84 on January 1st, 2024. Since then, ANGO shares have decreased by 8.4% and is now trading at $7.18.
View the best growth stocks for 2024 here
.

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) announced its quarterly earnings results on Tuesday, July, 16th. The medical instruments supplier reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.17) by $0.11. AngioDynamics's revenue was down 22.1% compared to the same quarter last year.

What is James C. Clemmer's approval rating as AngioDynamics' CEO?

34 employees have rated AngioDynamics Chief Executive Officer James C. Clemmer on Glassdoor.com. James C. Clemmer has an approval rating of 50% among the company's employees. This puts James C. Clemmer in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 47.0% of employees surveyed would recommend working at AngioDynamics to a friend.

Does AngioDynamics have any subsidiaries?

AngioDynamics subsidiaries include Eximo Medical Ltd., RadiaDyne LLC, Clinical Devices, Vortex Medical, Navilyst Medical Inc., FlowMedica, Oncovionic, and more.

Who are AngioDynamics' major shareholders?

AngioDynamics' top institutional shareholders include Assenagon Asset Management S.A. (0.99%), Dynamic Advisor Solutions LLC (0.11%) and Williams & Novak LLC (0.11%). Insiders that own company stock include James C Clemmer, James C Clemmer, Stephen A Trowbridge, Wesley Johnson, Dave Helsel, Scott Centea and Chad Thomas Campbell.
View institutional ownership trends
.

How do I buy shares of AngioDynamics?

Shares of ANGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of AngioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that AngioDynamics investors own include General Electric (GE), Intel (INTC), Oasis Petroleum (OAS), Advanced Micro Devices (AMD), Freeport-McMoRan (FCX), Amicus Therapeutics (FOLD) and Rigel Pharmaceuticals (RIGL).

This page (NASDAQ:ANGO) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners